U-251 In Vitro High Content Screening (HCS) Assay

This assay is to provide U-251-based In Vitro High Content Screening (HCS) Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.

U-251

Human

The U-251 cell line was established at the Wallenberg laboratory, Uppsala, Sweden, almost more than 40 years ago along with several other cell lines derived from human gliomas, and was derived from a male patient with malignant astrocytoma.

Glioblastoma

Oncology

In Vitro High Content Screening (HCS) Assay

U-251-cell based In Vitro High Content Screening (HCS) Assay

HCS is one of the latest techniques used in cancer drug discovery programs. Unlike traditional HTS platforms, HCS provides more visual information about the experiment being conducted. HCS is a very powerful tool for multivariate and quantitative data analysis. Cellbased HCS systems have also gained much attention in biological research and cancer drug discovery programs.

High-throughput Screening, High Content Screening and Reporter Gene Assays